Potential Involvement of Type I Interferon Signaling in Immunotherapy in Seasonal Allergic Rhinitis

Specific immunotherapy (SIT) reverses the symptoms of seasonal allergic rhinitis (SAR) in most patients. Recent studies report type I interferons shifting the balance between type I T helper cell (Th1) and type II T helper cells (Th2) towards Th2 dominance by inhibiting the differentiation of naive T cells into Th1 cells. As SIT is thought to cause a shift towards Th1 dominance, we hypothesized that SIT would alter interferon type I signaling. To test this, allergen and diluent challenged CD4+ T cells from healthy controls and patients from different time points were analyzed. The initial experiments focused on signature genes of the pathway and found complex changes following immunotherapy, which were consistent with our hypothesis. As interferon signaling involves multiple genes, expression profiling studies were performed, showing altered expression of the pathway. These findings require validation in a larger group of patients in further studies.

[1]  Mika Gustafsson,et al.  A validated gene regulatory network and GWAS identifies early regulators of T cell–associated diseases , 2015, Science Translational Medicine.

[2]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[3]  Colm E. Nestor,et al.  Sublingual immunotherapy alters expression of IL‐4 and its soluble and membrane‐bound receptors , 2014, Allergy.

[4]  F. Haddad,et al.  High‐dose sublingual immunotherapy in patients with uncontrolled allergic rhinitis sensitized to pollen: a real‐life clinical study , 2014, International forum of allergy & rhinology.

[5]  K. Nadeau,et al.  Immune Mechanisms of Sublingual Immunotherapy , 2014, Current Allergy and Asthma Reports.

[6]  J. C. de la Torre,et al.  Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection , 2014, Proceedings of the National Academy of Sciences.

[7]  T. Kündig,et al.  Intralymphatic immunotherapy: time interval between injections is essential. , 2014, The Journal of allergy and clinical immunology.

[8]  Colm E. Nestor,et al.  Profiling of human CD4+ T-cell subsets identifies the TH2-specific noncoding RNA GATA3-AS1. , 2013, The Journal of allergy and clinical immunology.

[9]  G. Canonica,et al.  Sublingual immunotherapy for allergic rhinitis and conjunctivitis. , 2013, Immunotherapy.

[10]  Julie G. Burel,et al.  Innate interferons inhibit allergen and microbial specific TH2 responses , 2012, Immunology and cell biology.

[11]  M. Benson,et al.  A pathway‐based approach to find novel markers of local glucocorticoid treatment in intermittent allergic rhinitis , 2011, Allergy.

[12]  Rafael A Irizarry,et al.  Gene set enrichment analysis made simple , 2009, Statistical methods in medical research.

[13]  Martin J Firth,et al.  A Network Modeling Approach to Analysis of the Th2 Memory Responses Underlying Human Atopic Disease1 , 2009, The Journal of Immunology.

[14]  Michael A Langston,et al.  A network-based analysis of the late-phase reaction of the skin. , 2006, The Journal of allergy and clinical immunology.

[15]  L. Platanias.  Mechanisms of type-I- and type-II-interferon-mediated signalling , 2005, Nature Reviews Immunology.

[16]  C. D. Krause,et al.  Interferons, interferon‐like cytokines, and their receptors , 2004, Immunological reviews.

[17]  Mats Rudemo,et al.  Gene profiling reveals increased expression of uteroglobin and other anti-inflammatory genes in glucocorticoid-treated nasal polyps. , 2004, The Journal of allergy and clinical immunology.

[18]  S. Pestka,et al.  The interferon gamma (IFN-γ) receptor: a paradigm for the multichain cytokine receptor , 1997 .

[19]  S. Pestka.  The human interferon-alpha species and hybrid proteins. , 1997, Seminars in oncology.

[20]  T. Herawan.  Computational and Mathematical Methods in Medicine , 2013 .

[21]  M Aguet,et al.  The IFN gamma receptor: a paradigm for cytokine receptor signaling. , 1997, Annual review of immunology.

[22]  K C Zoon,et al.  Interferons and their actions. , 1987, Annual review of biochemistry.

[23]  M. Benson,et al.  Trace: Tennessee Research and Creative Exchange Faculty Publications and Other Works --eecs Engineering --faculty Publications and Other Works a Module-based Analytical Strategy to Identify Novel Disease-associated Genes Shows an Inhibitory Role for Interleukin 7 Receptor in Allergic Inflammation a , 2022 .